For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
21
views
0
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
1 collections
    0
    shares
      1,444
      similar
       All similar
      Are you tired of sifting through news that doesn't interest you?
      Personalize your Karger newsletter today and get only the news that matters to you!

      Sign up

      • Record: found
      • Abstract: found
      • Article: found

      Selective Intra-Arterial Embolization for Advanced Extrascleral Uveal Melanoma

      case-report

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose: To report a treatment approach for advanced extrascleral uveal melanoma. Methods: We performed clinical examination including magnetic resonance imaging, computed tomography, angiography, and histopathologic analysis. Case: A 49-year-old healthy woman presented with a 7-year history of an enlarging pigmented mass in her right orbit. Malignant melanoma was diagnosed after biopsy with immunohistochemical stains. Treatment included selective intra-arterial embolization. Results: A significant reduction in tumor burden was seen 3 months after intra-arterial embolization. No complications were associated with the treatment. Conclusion: Selective intra-arterial embolization may allow adequate palliative therapy in select cases of advanced extrascleral uveal melanoma.

          Related collections

          Author and article information

          Journal
          Journal ID (publisher-id): OOP
          Journal ID (pmc): OOP
          Journal ID (doi): 10.1159/issn.2296-4657
          Title: Ocular Oncology and Pathology
          Publisher: S. Karger AG
          ISSN (Print): 2296-4681
          ISSN (Electronic): 2296-4657
          Publication date Subscription-year: 2018
          Publication date (Print): December 2017
          Publication date (Electronic): 19 July 2017
          Volume: 4
          Issue: 1
          Pages: 44-47
          Affiliations
          aDepartment of Ophthalmology, University of Puerto Rico, Río Piedras, Puerto Rico; bBascom Palmer Eye Institute, University of Miami, and cMurray Ocular Oncology and Retina, Miami, FL, USA
          Author notes
          *Víctor M. Villegas, MD, Bascom Palmer Eye Institute, 900 NW 17th Street, Miami, FL 33136 (USA), E-Mail v.villegas@med.miami.edu
          Article
          Publisher ID: 477772 Pmcid ID: PMC5757620 Other ID: Ocul Oncol Pathol 2018;4:44-47
          DOI: 10.1159/000477772
          PMC ID: PMC5757620
          PubMed ID: 29344498
          SO-VID: abfdf8cb-b24a-426d-a788-0a91f7d336c8
          Copyright © © 2017 S. Karger AG, Basel
          License:

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          Date received : 21 April 2017
          Date accepted : 22 May 2017
          Page count
          Figures: 5, References: 13, Pages: 4
          Categories
          Subject: Original Paper

          ScienceOpen disciplines: Vision sciences,Ophthalmology & Optometry,Pathology
          Keywords: Melanoma,Ocular melanoma,Malignant melanoma
          Data availability:
          ScienceOpen disciplines: Vision sciences, Ophthalmology & Optometry, Pathology
          Keywords: Melanoma, Ocular melanoma, Malignant melanoma

          Comments

          Comment on this article